collagen type IV (cIV) antibody and antigen (Recombinant protein)
Diagnostic collagen type IV (cIV) antibodies (anti-collagen type IV, anti-cIV) and antigens (recombinant collagen type IV (cIV) protein) for Liver diseases cIV detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Liver diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-cIV-Ag01 | Recombinant human cIV Protein | $3090.00 |
GMP-h-cIV-Ab01 | Anti-human cIV mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-cIV-Ab02 | Anti-human cIV mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-cIV-Ab03 | Anti-human cIV human monoclonal antibody (mAb) | $1953.00 |
GMP-h-cIV-Ab04 | Anti-human cIV human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Pruducts | GMP-h-cIV-Ag01 |
Product Name | Recombinant human cIV Protein |
Target/Biomarker | collagen type IV (cIV) |
Alias of Target/Biomarker | #N/A |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | collagen type IV (cIV) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation |
Products description | Recombinant Human collagen type IV (cIV) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-cIV-Ab01,GMP-h-cIV-Ab02 |
Product Name | Anti-human cIV mouse monoclonal antibody (mAb) |
Target/Biomarker | collagen type IV (cIV) |
Alias of Target/Biomarker | #N/A |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human collagen type IV (cIV) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other collagen type IV (cIV) antibodies in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human cIV mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other collagen type IV (cIV) antibodies. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-cIV-Ab03,GMP-h-cIV-Ab04 |
Product Name | Anti-human cIV human monoclonal antibody (mAb) |
Target/Biomarker | collagen type IV (cIV) |
Alias of Target/Biomarker | #N/A |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human collagen type IV (cIV) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other collagen type IV (cIV) antibodies in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human cIV mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The serum type IV collagen test is now used as a diagnostic aid for the detection of liver fibrosis and cirrhosis. Recently, a platelet count has been reported to be a useful marker for assessing the fibrotic stage in chronic hepatitis C.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.